Anne @Anne98, your wait for the Hybrid OmniPod “closed loop” system may not be too long. How about July 2021?
Omnipod 5 Hybrid Closed Loop pivotal trial is complete
The pivotal trial for Insulet’s Omnipod 5 hybrid closed loop, also known as Omnipod Horizon, is now complete – meaning that the technology is one step closer to becoming available for people with diabetes. Though the trial experienced a delay earlier this year, Insulet plans to share the results in February 2021 and to launch the system in the US before July 2021. This is a extract from the newsletter sent today by diaTribe:
Omnipod Horizon is an automated insulin delivery (AID) system that will integrate, or combine, the Omnipod 5 patch pump (worn for three days at a time) with a continuous glucose monitor (CGM) to predict sugar levels and dose insulin. Omnipod Horizon will first become available with the Dexcom G6 CGM, and later with Abbott’s FreeStyle Libre 2 CGM – it will be the first AID system with two CGM partners. The system will be controlled via a smartphone app (or through a special device, for people who don’t use smartphones). Insulet is focusing on making the system user-friendly and simple, with alarms and adjustable glucose targets (set between 100 and 150 mg/dl) allowing people new to AID to “ease” into the therapy by beginning with higher set points and working their way down.
You can read more about the Omnipod Horizon here.